The global moist wound dressings market size was valued at USD 4.05 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.4% from 2022 to 2030. Wound dressings have evolved from simple dressings that cover the wound to advanced products that release pharmaceutically active ingredients for accelerating the healing process and reducing pain and inflammation. Wound care is essential to enhance the healing process and minimize the risk of associated infections. The rising incidence of diabetic pressure, venous stasis, and foot ulcers are one of the key factors driving the market.
The COVID-19 pandemic had a profound effect on the capacity of healthcare systems to keep up with curative and preventive services, particularly for the more vulnerable population. During the pandemic, the wound treatment centers in Italy managed a major reduction in the frequency of hospital admissions, since just urgencies, like extreme infections or wound hemorrhagic complexities, were permitted in the hospitals.
The COVID-19 pandemic affected the consultations by primary-care clinicians, hospitalization, and diagnostic workup for moist wound care management. The restrictions that were imposed by the pandemic did not weaken wound-related QOL or home care. Many healthcare organizations together with governments adopted telemedicine for wound care management, especially in cases of severe wounds as it helped in minimizing the risk of infection and reducing contact between physicians and patients. Although, in Germany, telemedicine had a negligible impact on wound care management, despite its obvious advantages in containing the risk.
Furthermore, the launch of novel therapies such as electromagnetic therapy, electrical stimulation, nanotechnology, and the use of silver and other combination dressings are boosting market growth. These advancements ensure better wound care and thus increase product adoption. A major advancement in the market includes the ability of these dressings to regulate moisture at the wound site, which aids in the regeneration of tissue and reduces infection and pain. Advanced products facilitate wound protection, gas exchange, antibacterial protection, thermal insulation, and exudate absorption, thereby boosting the market growth.
In addition, the growing incidence of burn injuries is projected to boost moist wound dressings demand. As per the statistics by the WHO, every year, about 180,000 deaths occur due to burning injuries. Moreover, the growing geriatric population across the globe is estimated to support market expansion. As per the WHO estimates, the global geriatric population (aged 60 years and above) is anticipated to reach about 2 billion by 2050.
This age group is susceptible to injuries and chronic wounds, such as venous leg and pressure ulcers, which is expected to spur the market growth in the years to come. Emerging regions such as Southeast Asia are expected to witness considerable growth on account of the rising cases of burn injuries. Growing disposable income, rising awareness regarding these dressing products, and the availability of better quality products in such regions are also contributing to the market growth.
The foam dressings segment held the largest revenue share of over 20.0% in 2021 in terms of revenue due to the soft and comfortable feel of these dressings. Moreover, they help prevent and stop exudation from burn injuries, which is also driving the segment. Due to their highly absorbent nature, these dressings can be changed after around 3-4 days and are used for wounds with heavy exudation without the complication of maceration.
According to the American Burn Association, approximately 450,000 patients are hospitalized due to burns each year and the risk of infection is higher in these patients. Based on product, the market is segmented into foam dressings, hydrocolloid dressings, film dressings, alginate dressings, hydrogel dressings, collagen dressings, and other advanced dressings. These wound dressings are recommended for chronic wounds like pressure and diabetic foot ulcers and burn injuries as they help create and maintain a moist environment, which facilitates a faster healing process.
The chronic wounds segment held the largest revenue share of over 55.0% in 2021. This can be attributed to the rising number of various chronic wounds. For instance, according to new statistics by The British Diabetic Association, in 2021, around 4.1 million people in the U.K. were living with some type of diabetes, whereas 850,000 people were expected to be living with type 2 diabetes, which was yet to be diagnosed. Additionally, as per the NCBI, the annual incidence rate of diabetic foot ulcers is predicted to be around 2% - 5%. The lifetime risk of diabetic foot ulcers is projected to be 15% - 20%. Therefore, as a result of the above-mentioned factors, the chronic wound segment is expected to dominate the market during the forecast period.
The acute wounds segment is anticipated to be the fastest-growing application segment due to the increasing prevalence of the disease and related complications. Due to the availability of advanced wound dressing products, such ulcers can be treated and healed quickly while reducing hospital stays and overall costs.
The hospital's segment captured the largest revenue share of over 40.0% in 2021 and this trend is projected to continue over the forecast period. This growth can be primarily attributed to the rising number of surgeries performed in these settings. On the basis of end-use, the market can be categorized into hospitals, specialty clinics, home healthcare, and others.
The hospital segment is also driven by the increasing prevalence of chronic diseases and wounds. In addition, the high prevalence of hospital-acquired infections is anticipated to further drive the segment. The home care settings segment is anticipated to register a growth rate of 6.1% over the forecast period.
North America held the largest revenue share of over 45.0% in 2021 owing to the presence of the target population and increased patient awareness levels. The market is estimated to expand further due to the increasing cases of chronic wounds, such as diabetic foot and pressure ulcers, in the region. As per the CDC, around 2.5 million patients suffer from pressure ulcers annually. The easy availability of products as a result of the presence of major market players and their wide distribution network will also contribute to the regional market growth.
The Asia Pacific is expected to witness lucrative growth over the forecast period as this region holds potential growth opportunities for the market. Moreover, the presence of emerging nations like Thailand, Malaysia, and Singapore is anticipated to fuel market growth.
Frequent merger and acquisition activities are observed in the market, mainly to gain a competitive edge. For instance, in December 2017, Medline Industries entered into an agreement with Resource Optimization & Innovation (ROI). This agreement is anticipated to provide Medline the access to ROi’s products. Companies are also focusing on the development of advanced products to attract more customers.
Some prominent players in the global moist wound dressing market include:
3M Healthcare
Coloplast A/S
Medline Industries, Inc.
Cardinal Health, Inc.
B. Braun Melsungen AG
Smith & Nephew PLC
ConvaTec Group PLC
Derma Sciences, Inc.
Systagenix Wound Management Ltd.
Report Attribute |
Details |
Market size value in 2022 |
USD 4.26 billion |
Revenue forecast in 2030 |
USD 6.51 billion |
Growth Rate |
CAGR of 5.4% from 2022 to 2030 |
Base year for estimation |
2021 |
Historical data |
2018 - 2020 |
Forecast period |
2022 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2022 to 2030 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Product, application, end use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; Australia; South Korea; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; UAE |
Key companies profiled |
3M Healthcare; Coloplast A/S; Medline Industries, Inc.; Cardinal Health, Inc.; B. Braun Melsungen AG; Smith & Nephew PLC; ConvaTec Group PLC; Derma Sciences, Inc.; Systagenix Wound Management Ltd. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global moist wound dressings market report based on product, application, end-use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Foam Dressings
Hydrocolloid Dressings
Film Dressings
Alginate Dressings
Hydrogel Dressings
Collagen Dressings
Other Advanced Dressings
Application Outlook (Revenue, USD Million, 2018 - 2030)
Acute Wounds
Surgical & Traumatic Wounds
Burns
Chronic Wounds
Diabetic Foot Ulcers
Pressure Ulcers
Venous Leg Ulcers
Other Chronic Wounds
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Specialty Clinics
Home Healthcare
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
Colombia
MEA
South Africa
Saudi Arabia
UAE
b. The global moist wound dressings market size was estimated at USD 4.05 billion in 2021 and is expected to reach USD 4.26 billion in 2022.
b. The global moist wound dressings market is expected to grow at a compound annual growth rate of 5.44% from 2022 to 2030 to reach USD 6.51 billion by 2030.
b. The form dressing segment held the largest share in the global market in 2021 with a market share of more than 23.36% and is expected to maintain its position over the forecast period.
b. Some key players operating in the moist wound dressings market include 3M Healthcare; Coloplast A/S; Medline Industries, Inc.; Cardinal Health, Inc.; B. Braun Melsungen AG; Smith & Nephew PLC; ConvaTec Group PLC; Derma Sciences, Inc.
b. Key factors that are driving the moist wound dressings market growth include the rising incidence of various chronic wounds such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.